New exec director/virus and cell biology research chief is ex-FDA Blood & Blood Products Medi- cine & Science Div. Associate Director Robert Gerety, MD/PhD.
You may also be interested in...
Internal FDA emails obtained by the Environmental Working Group through a FOIA request indicate that the agency was moving toward rulemaking in 2016 to restrict or prohibit use of formaldehyde in heated hair-straightening cosmetics, but seemingly abandoned the initiative. That has Congress, NGOs and other stakeholders asking questions and renewing calls for cosmetics regulatory reform.
Expert outlines how pharma can create resilient and secure supply chains and some benefits of localization.
Product review report reveals multiple delays and missteps on route to market, holding valuable lessons for other gene therapy developers but also evidencing an ultimately welcoming environment.